treatment options for high risk early breast cancer
Published 1 year ago • 112 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer
-
4:03
monarche 4-year: abemaciclib endocrine therapy for hr , her2-, node-positive, high-risk early bc
-
1:30
exploring endocrine therapy innovations for high-risk hormone receptor-positive breast cancer
-
1:38
unanswered questions in the use of adjuvant therapy in early breast cancer
-
0:59
low-dose tamoxifen for the treatment of high-risk breast cancer
-
3:05
advancements in immunotherapy for high-risk hr breast cancer
-
1:32
sequencing treatment options in breast cancer
-
1:43:06
iapm kerala chapter webinar | grossing and interaoperative consultation in carcinoma breast
-
5:54
roxane: impact of 21-gene assay on treatment for early breast cancer
-
3:50
update from kaitlin for high-risk her2-positive early breast cancer
-
4:24
the latest treatment options for brca-mutated breast cancer
-
2:15
treatment strategies for her2 metastatic breast cancer
-
1:49
early breast cancer: do we need chemotherapy in low genomic/high clinical risk (er /her2-)?
-
6:48
how to use endocrine therapy in premenopausal women with er early breast cancer
-
1:12
impact of hormones on brca breast cancer risk
-
4:11
the latest in neo-adjuvant therapy for luminal breast cancer
-
3:12
combination treatments for premenopausal breast cancer: endocrine therapy and ovarian suppression
-
4:37
predict underestimates survival of patients with her2 early breast cancer
-
0:44
adcs in early breast cancer